SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-302210
Filing Date
2023-12-22
Accepted
2023-12-22 17:07:32
Documents
17
Period of Report
2023-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d630414d8k.htm   iXBRL 8-K 51568
2 EX-2.1 d630414dex21.htm EX-2.1 480754
3 EX-10.1 d630414dex101.htm EX-10.1 62966
4 EX-10.2 d630414dex102.htm EX-10.2 57822
5 EX-10.3 d630414dex103.htm EX-10.3 57783
6 EX-10.4 d630414dex104.htm EX-10.4 57758
  Complete submission text file 0001193125-23-302210.txt   1090385

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA krtx-20231221.xsd EX-101.SCH 2842
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20231221_lab.xml EX-101.LAB 17995
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20231221_pre.xml EX-101.PRE 11256
11 EXTRACTED XBRL INSTANCE DOCUMENT d630414d8k_htm.xml XML 3334
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 231510689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)